AnaptysBio, Inc. ANAB Repayment Of Advance Future Royalty And Milestones
Repayment Of Advance Future Royalty And Milestones at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept anab:RepaymentOfAdvanceFutureRoyaltyAndMilestones.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s repayment of advance future royalty and milestones.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s repayment of advance future royalty and milestones?
- AnaptysBio, Inc. (ANAB) reported repayment of advance future royalty and milestones of $12.81M in Q1 2026.
- How has AnaptysBio, Inc.'s repayment of advance future royalty and milestones changed year-over-year?
- AnaptysBio, Inc.'s repayment of advance future royalty and milestones decreased by 44.3% year-over-year, from $23.01M to $12.81M.
- What does repayment of advance future royalty and milestones mean?
- This reflects the cash outflows associated with the repayment of principal or milestone-related obligations tied to previous royalty financing agreements. It indicates the ongoing cost of servicing debt-like structures that were funded by future revenue rights. Consistent monitoring is essential to evaluate the company's long-term cash flow commitments.